Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News North European Oil Royalty Trust NRT

Energy Oil & Gas E&P
North European Oil Royalty Trust (the Trust) is a grantor trust which, on behalf of the owners of units of beneficial interest in the Trust (the unit owners), holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The rights are held under contracts with local German exploration and development subsidiaries of... see more

Recent & Breaking News (NYSE:NRT)

Novogen Engages Leading US Investor Relations Firm

PR Newswire April 1, 2015

Yale University and Novogen Release Data on Cantrixil Mode of Action

PR Newswire March 29, 2015

Potential of Anisina to Become Major New Chemotherapy Confirmed by Coda Study

PR Newswire March 18, 2015

Sky News, Helen Dalley interviews Dr Graham Kelly

PR Newswire March 10, 2015

Cantrixil Data to be Presented at Two Major Conferences

PR Newswire March 6, 2015

US Studies Confirm Ability of TRXE-009 to Kill Brain Cancer Stem Cells

PR Newswire March 4, 2015

Novogen to Present at AusBiotech "Broker Meets Biotech" Event

PR Newswire March 2, 2015

Novogen to Present at SACHS Cancer Bio Partnering & Investment Forum

PR Newswire February 22, 2015

Novogen Investor Briefing Well Received

PR Newswire February 19, 2015

North European Oil Royalty Trust Announces Net Income And Results For The First Quarter Of Fiscal 2015

PR Newswire February 13, 2015

Novogen Lodges Key Super-benzopyran Patent

PR Newswire February 11, 2015

Novogen to present at BIO & CEO Investor Conference 9th & 10th February, 2015

PR Newswire February 3, 2015

North European Oil Royalty Trust Announces The Distribution For The First Quarter Of Fiscal 2015

PR Newswire January 30, 2015

Novogen CEO to Present at Biotech and Money Conference in London

PR Newswire January 23, 2015

Novogen Announces Important Discovery in Regenerative Medicine Program

PR Newswire January 15, 2015

Novogen to Conduct Shareholder/Investor Briefing in New York

PR Newswire January 7, 2015

Novogen Raises An Additional A$1.75m in Private Placement to US Institutions for Aggregate Private Placement of A$5.85m

PR Newswire December 19, 2014

Novogen Announces Breakthrough Discovery in the Treatment of Melanoma

PR Newswire December 16, 2014

Novogen Provides Update On Progress Of Cantrixil Into The Clinic

PR Newswire December 15, 2014

North European Oil Royalty Trust Announces Net Income And Results For The Fourth Quarter Of Fiscal 2014

PR Newswire November 12, 2014